Hunan Er-Kang Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Hunan Er-Kang Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Hunan Er-Kang Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Cash from minority shareholders of subsidiaries21,854,6358.9E-41102015-09-30historic
Construction materials1,744,0887.0E-52022015-09-30historic
Net income424,340,9020.017252852015-09-30historic
Total comprehensive income430,541,8000.017512982015-09-30historic
Special reserve126,3781.0E-53022015-09-30historic
Operating profit457,919,1980.018623092015-09-30historic
Cash from other investing activities16,943,5006.9E-43232015-09-30historic
Total profit467,005,3970.018993302015-09-30historic
Cash paid for other investing activities700,0003.0E-53492015-09-30historic
Purchases of fixed assets and others318,677,9190.012964172015-09-30historic
Net change in cash186,264,8910.007574652015-09-30historic
Long term borrowings300,000,0000.01224942015-09-30historic
Net cashflow from financing activities290,927,3850.011835372015-09-30historic
Goodwill11,432,3724.6E-45742015-09-30historic
Cash paid for other financing activities2,265,0009.0E-56352015-09-30historic
Minority interest76,400,2280.003117512015-09-30historic
Net cash flows from investing activities-302,434,419-0.01237532015-09-30historic
Other current assets35,084,9180.001438102015-09-30historic
Notes receivable30,100,9730.001228142015-09-30historic
Comprehensive income attributable to minority shareholders-2,303,940-9.0E-58152015-09-30historic
Minority interests gain-2,303,940-9.0E-58292015-09-30historic
Short term borrowings356,503,8000.014498502015-09-30historic
Prepayment106,716,5320.004348552015-09-30historic
Cash paid for taxes125,766,1160.005118692015-09-30historic
Diluted eps00.08762015-09-30historic
Fixed assets940,360,9170.038239232015-09-30historic
Selling expenses54,473,1320.002219412015-09-30historic
Cash inflows from financing activities442,225,6730.017989502015-09-30historic
Financial expenses921,9174.0E-59572015-09-30historic
Intangible assets172,344,4070.007019802015-09-30historic
Inventories524,227,3790.021319942015-09-30historic
Cash paid for dividends, profits or interests52,533,2880.0021410182015-09-30historic
Revenue1,228,054,9280.0499310222015-09-30historic
Deferred tax assets17,439,0807.1E-410252015-09-30historic
Cash inflows from operating activities1,227,795,6470.0499210272015-09-30historic
Net cash and cash equivalents ending balance536,870,8280.0218310712015-09-30historic
Payroll payable15,347,9286.2E-410772015-09-30historic
Cash outflows from operating activities1,040,044,7630.0422911012015-09-30historic
Total non-current assets1,553,094,0170.0631511162015-09-30historic
Total cost of goods sold770,135,7300.0313111202015-09-30historic
Total liabilities1,009,137,4040.0410311592015-09-30historic
Other payables18,133,0127.4E-411912015-09-30historic
Accounts payable96,116,1970.0039112422015-09-30historic
Other receivables9,926,3074.0E-412432015-09-30historic
Non-operating loss44,1770.012742015-09-30historic
Total liabilities and equity3,136,033,0720.1275112802015-09-30historic
Capital reserve117,638,2110.0047812962015-09-30historic